Home > Insider Trading > Filing (0000899243-19-028597)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1358762	Reata Pharmaceuticals Inc	RETA	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1193284	William Rose	3963 Maple Avenue, Suite 200 Dallas TX 75219	Yes	No	Yes	Yes
1675029	E. Charles Gale	3963 Maple Avenue, Suite 200 Dallas TX 75219	No	No	Yes	Yes
1675042	Montrose Investments Gp, Llc	3963 Maple Avenue, Suite 200 Dallas TX 75219	No	No	No	Yes
1675064	P. Evelyn Rose	3963 Maple Avenue, Suite 200 Dallas TX 75219	No	No	No	Yes
1675066	Ira Rollover Fidelity Rose P. Evelyn	3963 Maple Avenue, Suite 200 Dallas TX 75219	No	No	No	Yes
1675112	Ira Rollover Fidelity Gale E. Charles	3963 Maple Avenue, Suite 200 Dallas TX 75219	No	No	No	Yes
1675137	Montrose Investments I, L.p.	3963 Maple Avenue, Suite 200 Dallas TX 75219	No	No	No	Yes
1724752	Trust Survivor's Rose Potter Evelyn	3963 Maple Avenue, Suite 200 Dallas TX 75219	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2019-11-08	15,869	$0.00	29,386	No	4	C	Direct
Class A Common Stock	Disposition	2019-11-18	400	$205.10	28,986	No	4	S	Direct
Class A Common Stock	Disposition	2019-11-18	600	$200.00	28,386	No	4	S	Direct
Class A Common Stock	Disposition	2019-11-19	2,000	$210.00	26,386	No	4	S	Direct
Class A Common Stock	Disposition	2019-11-20	591	$215.89	25,795	No	4	S	Direct
Class A Common Stock	Disposition	2019-11-20	2,000	$210.00	23,795	No	4	S	Direct
Class A Common Stock	Disposition	2019-11-20	2,000	$211.27	21,795	No	4	S	Direct
Class A Common Stock	Disposition	2019-11-20	2,000	$215.32	19,795	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Class B common stock	Acquisiton	2019-11-08	15,869	$0.00	15,869	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	11,618	Direct
Class A Common Stock	879,281	Indirect	By trust
Class A Common Stock	7,886	Indirect	See Footnote
Class A Common Stock	20	Indirect	By trust
Class A Common Stock	45	Indirect	By trust
Class A Common Stock	29	Indirect	See Footnote
Class A Common Stock	180,909	Indirect	By Montrose

Footnotes

The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
These shares are owned directly by Charles E. Gale.
These shares are owned directly by William E. Rose, a director of the issuer.
These shares are owned directly by the Survivor's Trust, a ten percent owner of the issuer, for Charles E. Gale and Evelyn P. Rose serve as co-trustees.
These shares are owned directly by Evelyn P. Rose Fidelity Rollover IRA and indirectly by Evelyn R. Rose.
These shares are owned indirectly by William E. Rose, a director of the issuer, as co-trustee of the Charles Henry Rose 2001 Trust.
These shares are owned indirectly by William E. Rose, a director of the issuer, as co-trustee of the John William Rose 2002 Trust.
These shares are owned directly by the Charles E. Gale Fidelity Rollover IRS and indirectly by Charles E. Gale.
These shares are owned directly by Montrose Investments I, L.P. ("Montrose"), and indirectly by William E. Rose, a director of the issuer, as sole shareholder and sole manager of the general partner of Montrose.